John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
ManpowerGroup
MAN
$2.86B
| $6.36M | 0.01% |
109,848
+49,038
| +81% | +$2.85M |
|
|
FACT
952
FACT II Acquisition Corp
FACT
$260M
| $6.36M | 0.01% |
634,375
| – | – |
|
953
Golub Capital BDC
GBDC
$3.44B
| $6.36M | 0.01% |
419,829
-305,364
| -42% | -$4.69M |
|
|
BEAG
954
Bold Eagle Acquisition Corp
BEAG
$338M
| $6.34M | 0.01% |
625,000
| – | – |
|
955
First Trust Utilities AlphaDEX Fund
FXU
$805M
| $6.32M | 0.01% |
+154,200
| New | +$6.1M |
|
|
HVII
956
Hennessy Capital Investment Corp VII
HVII
$181M
| $6.27M | 0.01% |
+634,375
| New | +$6.24M |
|
|
MRLN
957
Merlin Inc
MRLN
$347M
| $6.26M | 0.01% |
625,000
| – | – |
|
958
Groupon
GRPN
$798M
| $6.24M | 0.01% |
332,488
-5,876
| -2% | -$74.4K |
|
959
Customers Bancorp
CUBI
$2.67B
| $6.24M | 0.01% |
124,255
+68,171
| +122% | +$3.58M |
|
960
World Kinect Corp
WKC
$1.82B
| $6.23M | 0.01% |
219,547
-41,317
| -16% | -$1.17M |
|
|
OLO
961
DELISTED
Olo Inc
OLO
| $6.2M | 0.01% |
1,027,292
-387,751
| -27% | -$2.71M |
|
962
Hilltop Holdings
HTH
$2.22B
| $6.14M | 0.01% |
201,708
-34,548
| -15% | -$1.05M |
|
|
TWO
963
Two Harbors Investment
TWO
$1.28B
| $6.13M | 0.01% |
+458,524
| New | +$5.94M |
|
964
Werner Enterprises
WERN
$2.26B
| $6.12M | 0.01% |
209,017
-170,697
| -45% | -$5.73M |
|
965
National Beverage
FIZZ
$3.1B
| $6.12M | 0.01% |
147,390
+45,072
| +44% | +$1.86M |
|
966
PUT
Akamai
AKAM
$15.2B
| $6.11M | 0.01% |
75,900
-129,700
| -63% | -$11.6M |
|
967
Recursion Pharmaceuticals
RXRX
$1.74B
| $6.1M | 0.01% |
1,152,626
-507,883
| -31% | -$3.7M |
|
968
Hope Bancorp
HOPE
$1.78B
| $6.08M | 0.01% |
580,632
+234,419
| +68% | +$2.63M |
|
|
LB
969
LandBridge Co
LB
$2.47B
| $6.08M | 0.01% |
84,459
+60,751
| +256% | +$4.3M |
|
970
Renasant Corp
RNST
$3.79B
| $6.07M | 0.01% |
178,988
-31,185
| -15% | -$1.13M |
|
971
Dow Inc
DOW
$22.7B
| $6.07M | 0.01% |
+173,761
| New | +$6.67M |
|
|
TMHC
972
DELISTED
Taylor Morrison
TMHC
| $6.05M | 0.01% |
100,781
+60,489
| +150% | +$3.77M |
|
973
Atmus Filtration Technologies
ATMU
$3.93B
| $6.03M | 0.01% |
164,305
-109,313
| -40% | -$4.31M |
|
974
CONMED
CNMD
$1.54B
| $6.02M | 0.01% |
+99,678
| New | +$6.42M |
|
975
Camping World
CWH
$663M
| $6.01M | 0.01% |
371,702
-30,832
| -8% | -$630K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.